Login / Signup

[Non-specific prevention of COVID-19 during vaccination against a new coronavirus infection: results of a multicenter, double-blind, placebo-controlled, randomized clinical trial].

M G AvdeevaO N BelousovaE A OrlovaR F KhamitovY G ShvartsI E Kravchenko
Published in: Terapevticheskii arkhiv (2022)
Ergoferon is an effective and safe drug for the prevention of COVID-19 in people vaccinated against a new coronavirus infection.
Keyphrases
  • sars cov
  • double blind
  • placebo controlled
  • coronavirus disease
  • respiratory syndrome coronavirus
  • clinical trial
  • phase ii
  • phase iii
  • study protocol
  • phase ii study
  • emergency department
  • open label